“…As such, genetically stable RV vaccines that show broader efficacy and increased safety profiles may be needed. Comparative genomic studies, such as that described here, are expected to provide key information about RV 11,16,19,22,26,37,38,41,45,47,48,66,74,75,87,90,96,97,101,105,116,119,120,123,125,126,146,147,149,159,178,179,193,211,212,213,217,220,221,227,233,237,238,239,242,267,268,278 104, 108, 121, 125, 131, 135, 162, 173, 189, 199, 236, 254, 283, 322, 337, 338, 435, 514, 560, 577, 580, 586, 590, 593, 595, 617, 621, 689, 695, 698, 708, 713, 738, 750 dN/dS Ͼ 1 125, 131, 144, 145, 146, 173, 189, 236, 281, 283, 303, 311, 365, 577, 586, 590, 593, 594, 595, 689, 695, 738 evolution, thereby informing the design of future vaccines. The goal of the current study was to better understand human RV evolution by analyzing the genome sequences of strains found in...…”